SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
SCYX

Scynexis Inc (NASDAQ:SCYX)

US · Delayed Price · Currency is USD
Healthcare · Medical - Pharmaceuticals
$2.38-$0.23 (-8.64%)
 
Market cap
$15.0M
Insider Score
Health Score
Analyst consensus
Listed since
May 2, 2014
Market Cap$14.97M-56.8%
Revenue (ttm)$18.88M+544.0%
Net Income-$10.10M+60.1%
EPS-$1.17+72.7%
Shares Out6.29M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume155,967
Open$2.59
Previous Close$2.60
Day's Range$2.30 - $2.73
52-Week Range$2.30 - $9.12
Beta1.22
AnalystsBuy
Price Targetn/a
Earnings DateMar 3, 2027

About SCYX

SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.

Address
1 Evertrust Plaza, Jersey City, NJ, 07302-6548, US
Market Cap
15 million
Employees
18
Industrial Classification
Medical - Pharmaceuticals
Financial Health Score
Fair
From SCYX’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-8.64%
5 Days
-26.32%
1 Month
-37.53%
6 Months
-59.32%
1 Year
-56.81%

$SCYX stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in SCYX holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by SCYX's directors and management

Net Shares Purchased by Insiders−200k−100k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

SCYX Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New SCYX patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to SCYX from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in SCYX

VTIVanguard Morningstar Total Stock Market ETF$865.37K
VXFVanguard Extended Market ETF$483.30K
BSVOEA Bridgeway Omni Small-Cap Value ETF$40.00K
DFASDimensional - US Small Cap ETF$13.52K
DFMCU.S. Micro Cap Portfolio ETF$12.58K
DXUVU.S. Vector Equity Portfolio ETF Class Shares$5.93K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from SCYX’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
No data yet
—
Analyst Ratings
100% of score
60
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
1
Sells
0
Buy Value
$0
Distinct Buyers
1

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

BSVOEA Bridgeway Omni Small-Cap Value ETF0.00%

Weight is the stock’s share of each fund’s holdings.